ArticleBiometrics2022
Two-stage penalized regression screening to detect biomarker-treatment interactions in randomized clinical trials.
Jixiong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it